Transpulmin Suppository and Guaiacol Compared to Transpulmin Syrup in Pediatric Participants With Productive Cough (Transpulmin)
Randomized Clinical Trial Evaluating the Non-clinical Inferiority of Suppository Transpulmin and Suppository Guaiacol Compared to Transpulmin Syrup in Frames of Productive Cough of Infectious Origin in Pediatric Participants.
Sponsor: Ache Laboratorios Farmaceuticos S.A.
Terminated
The study stopped because after monitoring visits and data analysis we noticed a high number of protocol deviation that made impossible the results analysis.
Other terminated trials from Ache Laboratorios Farmaceuticos S.A.
More terminations from Ache Laboratorios Farmaceuticos S.A.
Listed as NCT02581397, this PHASE3 trial focuses on Cough and remains terminated or withdrawn. Sponsored by Ache Laboratorios Farmaceuticos S.A., it has been updated 8 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE3
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE3
▶ Show 3 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Terminated PHASE3
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Jan 2017 — May 2018 [monthly]
Recruiting PHASE3
First recorded
May 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Ache Laboratorios Farmaceuticos S.A.
For direct contact, visit the study record on ClinicalTrials.gov .